HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Клеточная линия HEK293 как платформа для получения рекомбинантных белков и вирусных векторов
2021-12-13
SCID: 54.1/r2ff2ey4
Discuss with AI
HEK293 cell linepost-translational modificationsrecombinant proteinssuspension cultureviral vectors
Figures from the paper
Abstract (AI)
Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the increased potential that the resulting biotherapeutics would carry more "human-like" post-translational modifications. Among the human cell lines, HEK293 is widely utilized due to its high transfectivity, rapid growth rate, and ability to grow in a serum-free, suspension culture. In this review, we discuss the use of HEK293 cells and its subtypes in the production of biotherapeutics. We also compare their usage against other commonly used host cell lines in each category of biotherapeutics and summarise the factors influencing the choice of host cell lines used.
Key Findings
1
HEK293 cells are widely used for recombinant protein and viral vector production because of their high transfectivity, rapid growth, and serum-free suspension-culture capability.
2
Host-cell selection depends on multiple factors that vary across biotherapeutic categories, including the desired product and production requirements.
3
Human cell expression platforms may produce biotherapeutics with more human-like post-translational modifications than nonhuman production systems.
4
The review examines HEK293 and its subtypes as production hosts for biotherapeutics, including comparisons with other commonly used host cell lines.
Research Object
HEK293 cells and their subtypes used as host cell lines for producing recombinant proteins and viral vectors
Research Subject
Their suitability and influencing factors for biotherapeutic production, including transfectivity, growth, culture mode, and human-like post-translational modifications
Publication Details
Publication Date
2021-12-13
Journal
Publisher
ISSN
Cited by
257
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest